Osaic Holdings
CLYM

Osaic Holdings’s Climb Bio CLYM Stock Holding History

Osaic Holdings’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.4K Sell
3,100
-300
-9% -$3.1K ﹤0.01% 5628
2026
Q1 		$23.3K Buy
3,400
+2,800
+467% +$16.2K ﹤0.01% 5756
2025
Q4 		$2.4K Sell
600
-22,000
-97% -$52.8K ﹤0.01% 7027
2025
Q3 		$45.1K Buy
22,600
+22,305
+7,561% +$41.4K ﹤0.01% 5376
2025
Q2 		$360 Buy
+295
New +$367 ﹤0.01% 7407
2024
Q4 		– Sell
-8,333
Closed -$21.7K – 7689
2024
Q3 		$21.7K Hold
8,333
– – ﹤0.01% 5341
2024
Q2 		$21.7K Hold
8,333
– – ﹤0.01% 5290
2024
Q1 		$21.7K Hold
8,333
– – ﹤0.01% 5313
2023
Q4 		$22.5K Hold
8,333
– – ﹤0.01% 5435
2023
Q3 		$21.9K Hold
8,333
– – ﹤0.01% 5505
2023
Q2 		$23.3K Buy
+8,333
New +$25.3K ﹤0.01% 5463

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings's CLYM Position: Q2 2026 in Review

Osaic Holdings reduced its Climb Bio (CLYM) stake by 8.8% in Q2 2026, selling an estimated $3.1K and leaving 3,100 shares worth $40.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5628.

Osaic Holdings first reported a position in CLYM in Q2 2023 and has held it in 11 quarters since. The position peaked at $45.1K in Q3 2025. 109 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Osaic Holdings held 3,100 shares of Climb Bio worth $40.4K as of Q2 2026.
  • Osaic Holdings sold 300 Climb Bio shares in Q2 2026, an estimated $3.1K.
  • Climb Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5628 holding.
  • Osaic Holdings first reported a position in Climb Bio in Q2 2023 and has held it in 11 quarters since.
  • Osaic Holdings's Climb Bio position peaked at $45.1K in Q3 2025.
  • 109 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.